Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial
- DOI
- 10.1161/jaha.119.014411
- Published
- 2020-03-03
- Container
- Journal of the American Heart Association
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1161/jaha.119.014411,
title = {Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial},
author = {Nina W. van der Hoeven and Gladys N. Janssens and Henk Everaars and Alexander Nap and Jorrit S. Lemkes and Guus A. de Waard and Peter M. van de Ven and Albert C. van Rossum and Javier Escaned and Hernan Mejia‐Renteria and Tim J. F. ten Cate and Jan J. Piek and Clemens von Birgelen and Marco Valgimigli and Roberto Diletti and Niels P. Riksen and Nicolas M. Van Mieghem and Robin Nijveldt and Maarten A. H. van Leeuwen and Niels van Royen},
year = {2020},
journal = {Journal of the American Heart Association},
doi = {10.1161/jaha.119.014411},
url = {https://doi.org/10.1161/jaha.119.014411}
}RIS
TY - JOUR TI - Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial AU - Nina W. van der Hoeven AU - Gladys N. Janssens AU - Henk Everaars AU - Alexander Nap AU - Jorrit S. Lemkes AU - Guus A. de Waard AU - Peter M. van de Ven AU - Albert C. van Rossum AU - Javier Escaned AU - Hernan Mejia‐Renteria AU - Tim J. F. ten Cate AU - Jan J. Piek AU - Clemens von Birgelen AU - Marco Valgimigli AU - Roberto Diletti AU - Niels P. Riksen AU - Nicolas M. Van Mieghem AU - Robin Nijveldt AU - Maarten A. H. van Leeuwen AU - Niels van Royen PY - 2020 JO - Journal of the American Heart Association DO - 10.1161/jaha.119.014411 UR - https://doi.org/10.1161/jaha.119.014411 ER -
APA
Hoeven, N. W. V. D., Janssens, G. N., Everaars, H., Nap, A., Lemkes, J. S., Waard, G. A. D., Ven, P. M. V. D., Rossum, A. C. V., Escaned, J., Mejia‐Renteria, H., Cate, T. J. F. T., Piek, J. J., Birgelen, C. V., Valgimigli, M., Diletti, R., Riksen, N. P., Mieghem, N. M. V., Nijveldt, R., Leeuwen, M. A. H. V., & Royen, N. V. (2020). Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.119.014411
Source records
- crossref · retrieved 2026-09-26T09:37:45.941Z